Literature DB >> 15047187

Phosphotyrosyl peptides and analogues as substrates and inhibitors of purple acid phosphatases.

Mohsen Valizadeh1, Gerhard Schenk, Kevin Nash, Geoff W Oddie, Luke W Guddat, David A Hume, John de Jersey, Terrence R Burke, Susan Hamilton.   

Abstract

Purple acid phosphatases are metal-containing hydrolases. While their precise biological role(s) is unknown, the mammalian enzyme has been linked in a variety of biological circumstances (e.g., osteoporosis) with increased bone resorption. Inhibition of the human enzyme is a possible strategy for the treatment of bone-resorptive diseases such as osteoporosis. Previously, we determined the crystal structure of pig purple acid phosphatase to 1.55A and we showed that it is a good model for the human enzyme. Here, a study of the pH dependence of its kinetic parameters showed that the pig enzyme is most efficient at pH values similar to those encountered in the osteoclast resorptive space. Based on the observation that phosphotyrosine-containing peptides are good substrates for pig purple acid phosphatase, peptides containing a range of phosphotyrosine mimetics were synthesized. Kinetic analysis showed that they act as potent inhibitors of mammalian and plant purple acid phosphatases, with the best inhibitors exhibiting low micromolar inhibition constants at pH 3-5. These compounds are thus the most potent organic inhibitors yet reported for the purple acid phosphatases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047187     DOI: 10.1016/j.abb.2004.01.008

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  Potential bio-protective effect of copper compounds: mimicking SOD and peroxidases enzymes and inhibiting acid phosphatase as a target for anti-osteoporotic chemotherapeutics.

Authors:  Nancy Martini; Juliana E Parente; Franco D Alessandro; Marilin Rey; Alberto Rizzi; Patricia A M Williams; Evelina G Ferrer
Journal:  Mol Biol Rep       Date:  2018-12-01       Impact factor: 2.316

2.  The divalent metal ion in the active site of uteroferrin modulates substrate binding and catalysis.

Authors:  Natasa Mitić; Kieran S Hadler; Lawrence R Gahan; Alvan C Hengge; Gerhard Schenk
Journal:  J Am Chem Soc       Date:  2010-05-26       Impact factor: 15.419

3.  A new heterobinuclear FeIIICuII complex with a single terminal FeIII-O(phenolate) bond. Relevance to purple acid phosphatases and nucleases.

Authors:  Mauricio Lanznaster; Ademir Neves; Adailton J Bortoluzzi; Veronika V E Aires; Bruno Szpoganicz; Hernán Terenzi; Patricia Cardoso Severino; Julie M Fuller; Simon C Drew; Lawrence R Gahan; Graeme R Hanson; Mark J Riley; Gerhard Schenk
Journal:  J Biol Inorg Chem       Date:  2005-04-21       Impact factor: 3.358

4.  Phosphate forms an unusual tripodal complex with the Fe-Mn center of sweet potato purple acid phosphatase.

Authors:  Gerhard Schenk; Lawrence R Gahan; Lyle E Carrington; Natasa Mitic; Mohsen Valizadeh; Susan E Hamilton; John de Jersey; Luke W Guddat
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-29       Impact factor: 11.205

5.  Guanidine- and purine-functionalized ligands of FeIIIZnII complexes: effects on the hydrolysis of DNA.

Authors:  Claudia Pereira; Giliandro Farias; Filipy G Maranha; Nathalia Castilho; Gerhard Schenk; Bernardo de Souza; Hernán Terenzi; Ademir Neves; Rosely A Peralta
Journal:  J Biol Inorg Chem       Date:  2019-07-02       Impact factor: 3.358

6.  The reaction mechanism of the Ga(III)Zn(II) derivative of uteroferrin and corresponding biomimetics.

Authors:  Sarah J Smith; Annelise Casellato; Kieran S Hadler; Natasa Mitić; Mark J Riley; Adailton J Bortoluzzi; Bruno Szpoganicz; Gerhard Schenk; Ademir Neves; Lawrence R Gahan
Journal:  J Biol Inorg Chem       Date:  2007-08-15       Impact factor: 3.358

7.  Probing the role of the divalent metal ion in uteroferrin using metal ion replacement and a comparison to isostructural biomimetics.

Authors:  Gerhard Schenk; Rosely A Peralta; Suzana Cimara Batista; Adailton J Bortoluzzi; Bruno Szpoganicz; Andrew K Dick; Paul Herrald; Graeme R Hanson; Robert K Szilagyi; Mark J Riley; Lawrence R Gahan; Ademir Neves
Journal:  J Biol Inorg Chem       Date:  2007-10-16       Impact factor: 3.358

8.  Diethylalkylsulfonamido(4-methoxyphenyl)methyl)phosphonate/phosphonic acid derivatives act as acid phosphatase inhibitors: synthesis accompanied by experimental and molecular modeling assessments.

Authors:  Nahid Alimoradi; Mohammad Reza Ashrafi-Kooshk; Mohsen Shahlaei; Shabnam Maghsoudi; Hadi Adibi; Ross P McGeary; Reza Khodarahmi
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-21       Impact factor: 5.051

9.  Identification of a non-purple tartrate-resistant acid phosphatase: an evolutionary link to Ser/Thr protein phosphatases?

Authors:  Kieran S Hadler; Thomas Huber; A Ian Cassady; Jane Weber; Jodie Robinson; Allan Burrows; Gregory Kelly; Luke W Guddat; David A Hume; Gerhard Schenk; Jack U Flanagan
Journal:  BMC Res Notes       Date:  2008-09-04

10.  Crystal structures of a purple acid phosphatase, representing different steps of this enzyme's catalytic cycle.

Authors:  Gerhard Schenk; Tristan W Elliott; Eleanor Leung; Lyle E Carrington; Natasa Mitić; Lawrence R Gahan; Luke W Guddat
Journal:  BMC Struct Biol       Date:  2008-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.